The National Cancer Institute in the USA is supporting the new vaccine developed at the MedUni Vienna against the human papillomavirus (HPV) with at least US$ 3.5 million. This is a major success for the developers and means that the foundations can now be laid for the clinical trials needed for licensing as a vaccine.


New investigation methods using functional magnetic resonance tomography (fMRT) offer insights into fetal brain development. These "in vivo" observations will uncover different stages of the brain's development. A research group...

The effect that genes have on our brain depends on our age. These are the findings of a group of researchers from the MedUni Vienna. It has been known for a number of years that particular genetic variations are of importance for...

Stroma cells are derived from connective tissue and may critically influence tumour growth. This knowledge is not new. However, bioanalyst Christopher Gerner and an interdisciplinary team from the University of Vienna and the...



10 Jahre MedUni Wien

3. November 2014
Ort: Hörsaalzentrum der MedUni Wien im AKH, Ebene 7/8

11 bis 13 Uhr Festakt
13.30 bis 18 Uhr Zukunftstag mit Themeninseln und Diskussionspodien

06.-08.11.2014Wiener Radiologisches Symposium
Ort: Van Swieten Saal, Van-Swieten-Gasse 1a, 1090 Wien
10./11.11.2014EAN EAS Symposium
Ort: Van Swieten Saal, Van-Swieten-Gasse 1a, 1090 Wien
19 Uhr
Blatt für Blatt - Die Schätze der Josephinischen Bibliothek
Ort: Josephinum, Währinger Straße 25, 1090 Wien

» zum Kalender   

© MedUni Wien  | 

Medizinische Universität Wien, Spitalgasse 23, A-1090 Wien, Tel.: +43 1 40 160-0